Effect of surgical and biochemical castration and an antiandrogen on patients with stage D2 prostatic cancer: preliminary results.
D000813:Anilides / Q000627:therapeutic use*; D005485:Flutamide / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000628:therapy*; D017329:Triptorelin Pamoate
D000813:Anilides; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; D005485:Flutamide